Envestnet Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$200M Sell
448,988
-21,340
-5% -$9.5M 0.06% 307
2025
Q1
$228M Buy
470,328
+47,630
+11% +$23.1M 0.07% 262
2024
Q4
$170M Buy
422,698
+19,630
+5% +$7.9M 0.05% 325
2024
Q3
$187M Sell
403,068
-11,992
-3% -$5.58M 0.06% 293
2024
Q2
$195M Buy
415,060
+11,751
+3% +$5.51M 0.07% 261
2024
Q1
$169M Sell
403,309
-9,320
-2% -$3.9M 0.06% 290
2023
Q4
$168M Buy
412,629
+1,143
+0.3% +$465K 0.07% 280
2023
Q3
$143M Buy
411,486
+105,232
+34% +$36.6M 0.07% 286
2023
Q2
$108M Sell
306,254
-1,145,620
-79% -$403M 0.05% 322
2023
Q1
$92.7M Buy
1,451,874
+1,167,674
+411% +$74.6M 0.04% 346
2022
Q4
$82.1M Buy
284,200
+14,768
+5% +$4.26M 0.04% 359
2022
Q3
$78M Buy
269,432
+13,885
+5% +$4.02M 0.04% 339
2022
Q2
$72M Sell
255,547
-52,192
-17% -$14.7M 0.04% 353
2022
Q1
$80.3M Buy
307,739
+38,499
+14% +$10M 0.04% 357
2021
Q4
$59.1M Buy
269,240
+20,854
+8% +$4.58M 0.03% 438
2021
Q3
$45.1M Buy
248,386
+53,642
+28% +$9.73M 0.02% 489
2021
Q2
$39.3M Sell
194,744
-13,933
-7% -$2.81M 0.02% 525
2021
Q1
$44.8M Buy
208,677
+19,743
+10% +$4.24M 0.03% 440
2020
Q4
$44.7M Sell
188,934
-108
-0.1% -$25.5K 0.03% 380
2020
Q3
$51.4M Buy
189,042
+25,601
+16% +$6.97M 0.05% 298
2020
Q2
$47.4M Buy
163,441
+49,186
+43% +$14.3M 0.05% 295
2020
Q1
$27.2M Buy
114,255
+20,284
+22% +$4.83M 0.03% 367
2019
Q4
$20.6M Buy
93,971
+6,621
+8% +$1.45M 0.02% 522
2019
Q3
$14.8M Buy
87,350
+3,372
+4% +$571K 0.02% 585
2019
Q2
$15.4M Buy
83,978
+3,297
+4% +$605K 0.02% 564
2019
Q1
$14.8M Buy
80,681
+9,146
+13% +$1.68M 0.02% 542
2018
Q4
$11.9M Buy
71,535
+58,803
+462% +$9.74M 0.02% 544
2018
Q3
$2.45M Sell
12,732
-13,821
-52% -$2.66M ﹤0.01% 568
2018
Q2
$4.51M Buy
26,553
+8,887
+50% +$1.51M 0.01% 524
2018
Q1
$2.88M Sell
17,666
-15,954
-47% -$2.6M 0.01% 574
2017
Q4
$5.04M Buy
33,620
+1,373
+4% +$206K 0.01% 594
2017
Q3
$4.9M Buy
32,247
+8,088
+33% +$1.23M 0.01% 560
2017
Q2
$3.11M Buy
24,159
+5,525
+30% +$711K 0.01% 754
2017
Q1
$2.04M Buy
18,634
+3,597
+24% +$393K 0.01% 928
2016
Q4
$1.11M Sell
15,037
-2,668
-15% -$197K ﹤0.01% 1143
2016
Q3
$1.54M Sell
17,705
-9,276
-34% -$809K 0.01% 1053
2016
Q2
$2.32M Sell
26,981
-2,069
-7% -$178K 0.01% 950
2016
Q1
$2.31M Sell
29,050
-1,997
-6% -$159K 0.01% 915
2015
Q4
$3.91M Sell
31,047
-3,653
-11% -$460K 0.02% 677
2015
Q3
$3.61M Buy
34,700
+2,553
+8% +$266K 0.02% 697
2015
Q2
$3.97M Buy
32,147
+1,895
+6% +$234K 0.02% 715
2015
Q1
$3.57M Buy
30,252
+30,062
+15,822% +$3.55M 0.02% 712
2014
Q4
$23K Buy
190
+12
+7% +$1.45K ﹤0.01% 1695
2014
Q3
$20K Buy
178
+83
+87% +$9.33K ﹤0.01% 1889
2014
Q2
$9K Sell
95
-61
-39% -$5.78K ﹤0.01% 2102
2014
Q1
$11K Sell
156
-48
-24% -$3.39K ﹤0.01% 1854
2013
Q4
$15K Sell
204
-400
-66% -$29.4K ﹤0.01% 1602
2013
Q3
$46K Buy
604
+10
+2% +$762 ﹤0.01% 1221
2013
Q2
$48K Buy
+594
New +$48K ﹤0.01% 1179